3 Reasons BLCO is Risky and 1 Stock to Buy Instead [Yahoo! Finance]
Bausch + Lomb Corporation (BLCO)
Company Research
Source: Yahoo! Finance
Its shares have yielded a 10.4% return over the last six months, beating the S&P 500 by 11.7%. This run-up might have investors contemplating their next move. Is there a buying opportunity in Bausch + Lomb, or does it present a risk to your portfolio? See what our analysts have to say in our full research report, it's free Why Is Bausch + Lomb Not Exciting? We're glad investors have benefited from the price increase, but we're swiping left on Bausch + Lomb for now. Here are three reasons we avoid BLCO and a stock we'd rather own. 1. EPS Trending Down We track the long-term change in earnings per share (EPS) because it highlights whether a company's growth is profitable. Bausch + Lomb's full-year EPS dropped significantly over the last three years. We tend to steer our readers away from companies with falling revenue and EPS, where diminishing earnings could imply changing secular trends and preferences. If the tide turns unexpectedly, Bausch + Lomb's low margin of safety c
Show less
Read more
Impact Snapshot
Event Time:
BLCO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BLCO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BLCO alerts
High impacting Bausch + Lomb Corporation news events
Weekly update
A roundup of the hottest topics
BLCO
News
- A Bausch + Lomb Director Just Bought $77,000 in Stock. That's Only Half the Story [Yahoo! Finance]Yahoo! Finance
- Bausch + Lomb Corporation (BLCO) Discusses Glaucoma Pipeline Focus With Updates on BL1107 and Elios Transcript [Seeking Alpha]Seeking Alpha
- Ophthalmic Diagnostic Devices Market Size to Hit USD 5.22 Billion by 2035 Due to Growing Demand for Early Eye Disease Detection – SNS Insider [Yahoo! Finance]Yahoo! Finance
- Bausch + Lomb Announces Positive 24-Month U.S. Data on the ELIOS™ System for Treatment of Glaucoma [Yahoo! Finance]Yahoo! Finance
- Bausch + Lomb Announces Positive 24-Month U.S. Data on the ELIOS™ System for Treatment of GlaucomaBusiness Wire
BLCO
Earnings
- 2/18/26 - Miss
BLCO
Sec Filings
- 3/10/26 - Form 4
- 3/10/26 - Form 4
- 3/10/26 - Form 4
- BLCO's page on the SEC website